Learning Objectives

For information on Hematology Update 2019 learning objectives, please see below. Information on our 2020 course will be available later this year. 

 

At the conclusion of this activity, participants should be able to:

 

  • State advances in the scientific understanding of acute myeloid leukemia
  • Discuss current and evolving AML therapeutic strategies
  • Summarize current applications of bone marrow transplantation and hematopoietic stem cell transplantation in the management of malignant diseases
  • Describe the role of CAR T-cell therapy in the treatment of including acute myeloid leukemia, chronic lymphocytic leukemia and other hematologic malignancies
  • Outline current advances in treatment for chronic lymphocytic leukemia
  • Review current guidelines for the management of coagulation disorders
  • Outline therapies of choice for venous thromboembolism and thrombotic thrombocytopenic purpura
  • Define the factors that influence treatment decisions for patients with non-Hodgkin and Hodgkin lymphoma
  • Summarize diagnostic and therapeutic criteria for myeloproliferative neoplasms
  • Apply insights from current understanding and emerging data on multiple myeloma when formulating individualized treatment plans